Shp2 was the first phosphatase to be identified as a human oncoprotein6,7, and a large body of experimental and clinical studies has indicated that the hyperactivation of Shp2 contributes to tumour progression in, for example, breast cancer8–11. The gene discussed is PTPN11; the disease is neoplasm.